What Causes Fatty Infiltration of Muscle?

Understand the underlying mechanisms and diverse contributors behind fat infiltration in muscle, and its implications for muscle quality.

Fatty infiltration of muscle, often called myosteatosis, happens when fat accumulates in and around muscle fibers that should be occupied by contractile tissue. The causes are numerous and often overlapping: aging, physical inactivity, tendon or nerve injuries, obesity, metabolic disease, chronic inflammation, hormonal shifts, and even the type of fat you eat can all contribute. At a cellular level, a specific population of stem-like cells called fibro-adipogenic progenitors plays a central role, essentially switching from a muscle-supporting identity to a fat-producing one when the local environment goes wrong. Understanding why muscle becomes fatty matters because it is not just a cosmetic or incidental finding on a scan; it is tied to real losses in strength, mobility, metabolic health, and even survival.

The Cells That Make Muscle Turn Fatty

Muscle tissue contains more than just muscle fibers. Nestled between them are resident stem cells that can develop into several cell types depending on the signals they receive. The most important of these for fatty infiltration are fibro-adipogenic progenitors, or FAPs. Under normal conditions, FAPs support muscle repair after injury by clearing damaged tissue and helping muscle satellite cells rebuild fibers. But when the repair process stalls or the local environment shifts, FAPs instead differentiate into fat cells, filling the space between and within muscle fibers with lipid droplets.

The rotator cuff is a telling example. Compared to other muscle groups, the rotator cuff appears to have an unusually high density of FAPs even before injury. When a massive tendon tear occurs, those progenitors rapidly tip toward fat production, and the resulting fatty infiltration is difficult to reverse even after surgical repair. Animal models confirm that fatty infiltration begins soon after tendon injury and becomes largely permanent once established.

FAPs are not the only culprits. Laboratory experiments have shown that muscle satellite cells themselves, the classic muscle stem cells, can be coaxed into becoming fat-like cells if certain genetic switches are disrupted or if they are exposed to particular chemical signals. Knocking out the gene MyoD, which normally locks satellite cells into a muscle-building fate, causes them to accumulate fat instead. Similarly, exposing bovine satellite cells to a drug that activates the fat-regulating receptor PPARγ pushes them to accumulate lipid droplets and turn on fat-specific genes, even without the usual cocktail needed to produce fat cells. In short, the boundary between “muscle cell” and “fat cell” is less fixed than you might imagine. The wrong environment can blur it.

Aging as the Most Common Driver

If you have not injured a tendon or been immobilized for weeks, the most likely reason for increased muscle fat is simply getting older. An interdisciplinary workshop convened by the U.S. National Institute on Aging described myosteatosis as an ectopic fat depot that grows with age and correlates negatively with muscle mass, strength, and mobility. The process is gradual and often invisible until muscle function starts to decline. Imaging studies of older adults frequently reveal substantial fat replacement in muscles that still look normal from the outside.

Several age-related changes converge to produce this effect. Mitochondrial volume in muscle tends to drop with age, meaning less capacity to burn fat for fuel. Hormonal shifts reduce the anabolic signals that keep muscle fibers robust. Physical activity levels decline, removing the mechanical stimulus that suppresses FAP differentiation into fat. And low-grade chronic inflammation, sometimes called “inflammaging,” creates a chemical environment that favors adipogenesis over myogenesis. None of these alone fully explains age-related muscle fat, but together they make it almost inevitable without deliberate countermeasures.

Disuse and Immobilization

You do not need to age decades for muscle fat to appear. Simple disuse can trigger it remarkably fast. A study using dry immersion, a model that simulates bed rest by removing weight-bearing forces, found that just three days of immobilization was enough to shrink muscle fiber size by about 10% and increase markers of fat cell development within the muscle. Proteins associated with fat droplet formation and late-stage adipogenic signaling were all elevated after that brief period of inactivity.

A systematic review of bed rest and immobilization studies confirmed that muscle disuse promotes fat infiltration, with especially prominent increases in the lumbar spine muscles. The lower back muscles appear particularly vulnerable to unloading, which may partly explain why chronic low-back pain patients often show marked fatty replacement of their paraspinal muscles on MRI. The clinical implication is that prolonged hospital stays, cast immobilization after fractures, and sedentary lifestyles all create favorable conditions for fat to quietly replace functional muscle.

Tendon Tears and Nerve Damage

Orthopedic injuries that disconnect a muscle from its tendon or disrupt its nerve supply are among the most potent triggers of fatty infiltration. Rotator cuff tears are the most studied example. When a tendon detaches, the muscle retracts, loses its normal mechanical loading, and undergoes rapid fatty change. Adding nerve damage on top of the tendon tear makes the infiltration far worse: in a rat model, animals with both a tendon cut and nerve ligation developed significantly more muscle fat at every time point than animals with the tendon cut alone.

The signaling pathway behind injury-driven fatty infiltration involves mTOR, a central cell-growth regulator. After combined rotator cuff tear and nerve injury in rats, mTOR signaling ramped up and activated transcription factors that push cells toward fat production. When researchers blocked mTOR with the drug rapamycin, fatty infiltration decreased, suggesting this pathway could eventually become a therapeutic target. For now, the clinical reality is sobering: once fatty infiltration sets in after a major rotator cuff tear, even successful surgical repair often fails to reverse it, and the remaining fat undermines the strength the repaired tendon can transmit.

Inflammation as an Accelerant

Inflammation does not just accompany fatty infiltration; it actively drives it. After nerve injury in animal models, muscles showed elevated levels of the pro-inflammatory molecules IL-6 and TNF-α alongside increased expression of the fat-producing genes PPARγ and C/EBPα. The inflammatory reaction and the adipogenic switch appear to be tightly coupled.

Systemic inflammation matters too. A study using hypercholesterolemic miniature pigs, animals with chronically elevated cholesterol and low-grade inflammation throughout their bodies, found that their rotator cuff muscles developed chronic inflammation, elevated pro-inflammatory markers, and significant intramuscular fat even without any surgical injury. The animals also showed activation of a molecular axis involved in muscle wasting. This finding has practical relevance: people with metabolic conditions that keep their inflammatory markers chronically elevated may be priming their muscles for fatty infiltration independently of injury or inactivity.

Metabolic Overflow and Obesity

When subcutaneous fat runs out of storage capacity, surplus energy gets redirected to organs that were never designed to hold large amounts of lipid. This process, called ectopic fat deposition, sends fat into the liver, the pancreas, and skeletal muscle. It is not the stored fat per se that causes trouble but the lipid intermediates that accumulate alongside it, disrupting the normal metabolic machinery of those tissues.

Imaging studies bear this out. When researchers measured fat inside muscles using MRI in people with and without obesity, the two groups told different stories. Lean individuals had more fat inside muscle fibers than between them, but in people with obesity, the two fat pools were equal and both were significantly elevated. People with prediabetes or type 2 diabetes had even higher levels of both types of muscle fat compared to those with normal blood sugar. The connection between metabolic disease and myosteatosis runs in both directions: excess body fat drives fat into muscle, and the fat that arrives in muscle worsens insulin resistance, which in turn promotes more ectopic fat storage.

How Muscle Fat Disrupts Insulin Signaling

The lipid intermediates that accumulate inside fatty muscle are more metabolically active than simple stored fat. Ceramides, a class of waxy lipid molecules, have emerged as a key link between muscle fat and insulin resistance. Research in obese humans and animals shows that ceramide buildup in tissues tracks closely with diabetes, hypertension, and cardiovascular disease. Within muscle cells, ceramides concentrated near the cell membrane were inversely related to insulin sensitivity, and these lipids also impaired mitochondrial function when applied to isolated mitochondria in the lab.

There is an interesting wrinkle here. Highly trained endurance athletes also carry elevated levels of some of these lipid intermediates in their muscles, yet they remain extremely insulin sensitive. This so-called “athlete’s paradox” suggests that total quantity of intramuscular lipid is not the whole story. Athletes appear to store and compartmentalize these fats differently, turning them over rapidly for fuel rather than letting them accumulate as toxic intermediates. The lesson is that it is not just how much fat is in the muscle but how actively the muscle uses it that determines whether the fat becomes harmful.

The Mitochondrial Connection

Mitochondria are the primary site where muscle cells burn fat for energy. When mitochondrial fat-burning capacity drops, unburned lipid accumulates in the muscle. Targeted studies have shown that mitochondrial dysfunction and reduced fatty acid oxidation likely lead directly to lipid buildup in myosteatosis.

An important nuance is whether the problem lies in the mitochondria themselves or in how many of them a muscle contains. Research comparing lean and obese individuals found that individual mitochondria from obese subjects were not inherently broken. They could oxidize fat at normal rates in isolation. The issue was that obese muscles simply contained less total mitochondrial volume, leading to lower whole-muscle fat-burning capacity. Meanwhile, a genetic mouse model that severely blocked mitochondrial fat entry showed what happens when the machinery is truly impaired: the muscles accumulated lipid droplets, ceramides, and diacylglycerols while the animals compensated by burning more carbohydrate and moving less. Both routes, fewer mitochondria and less capable mitochondria, converge on the same outcome: fat that should have been burned instead stays put.

Hormones and Glucocorticoids

Cortisol and its pharmaceutical cousins, glucocorticoid drugs like prednisone, are powerful promoters of muscle fat. Prolonged or high-dose glucocorticoid therapy leads to a gradual decline in muscle mass and an increase in fat within the muscle. In patients with nephrotic syndrome treated with prednisone, researchers found impaired grip strength and ultrasound evidence of increased fat infiltration in multiple leg muscles, with the degree of damage correlating with the total dose and duration of treatment.

Cushing’s syndrome, where the body produces excess cortisol on its own, provides a natural experiment. Patients with Cushing’s showed significantly greater muscle fat in the thigh compared with matched controls, roughly 21% fat versus 18% in the combined thigh compartments. Strikingly, this fat persisted even after successful treatment of the cortisol excess, suggesting that glucocorticoid-induced muscle fat is difficult to reverse once established. Menopause, with its decline in estrogen and shifts in body composition, is another hormonal transition associated with increased ectopic fat deposition, though the specific contribution to muscle fat is harder to isolate from the general effects of aging.

What You Eat Matters Too

Diet influences muscle fat through at least two routes: the total caloric surplus that drives ectopic fat storage, and the specific types of fatty acids that reach the muscle. In cell culture experiments, exposing muscle cells to palmitic acid, the most common saturated fatty acid in the Western diet, rapidly produced lipid droplet accumulation, a spike in ceramides, and a loss of insulin-stimulated protein building. But when omega-3 fatty acids like DHA or the omega-6 arachidonic acid were added alongside the palmitic acid, they prevented cell death and partially reversed the toxic lipid buildup.

Population-level data hint at similar patterns. A multicenter study found that a dietary pattern heavy in animal-derived nutrients and carbohydrates was associated with decreased muscle density, a proxy for increased muscle fat, in men. Conversely, low intake of bean protein was also linked to lower muscle density. These are associations rather than proven cause-and-effect, but they align with the cellular evidence that the fatty acid composition reaching your muscles, not just the total quantity, shapes whether fat accumulates in harmful ways.

Genetic and Epigenetic Susceptibility

Not everyone exposed to the same triggers develops the same amount of muscle fat, and genetics is part of the reason. A population-based study identified several gene variants associated with lean muscle mass, including variants in the FTO gene, which is well known for its links to obesity and fat gain. People carrying certain FTO variants tend toward greater overall adiposity, and it is plausible this extends to fat deposition within muscle, though direct proof of that specific link is still limited.

Epigenetics adds another layer. In severely obese women, the gene CPT1B, which encodes a key enzyme for shuttling fat into mitochondria for burning, responded poorly to lipid exposure compared with lean women. The difference was traced to changes in DNA methylation and histone modifications at the CPT1B gene’s control region. Essentially, obesity altered the chemical packaging around this gene in a way that muted the muscle’s ability to ramp up fat burning when fat arrived. This kind of epigenetic blunting may help explain why the metabolic problems of obesity become self-reinforcing: the fatter you get, the harder it becomes for your muscles to burn the incoming fat, and the cycle deepens.

Can Exercise Reverse It?

Exercise is the most studied intervention for myosteatosis, and the news is cautiously good but not universally so. A systematic review and meta-analysis of exercise trials found that exercise significantly reduced the volume of lipid infiltration in muscle compared with control groups and improved a measure of muscle quality called radiation attenuation. The effect was seen across populations at risk for obesity and sarcopenia-related disability.

But the results are not uniform across all muscles or all situations. A randomized controlled trial of high-intensity resistance training in elderly men with osteoporosis and low muscle mass found that despite strong enough mechanical loading to improve lumbar spine bone density, the training had no detectable effect on fat infiltration in the paraspinal muscles. The researchers suggested that fat infiltration in those muscles may be either irreversible or resistant to exercise for reasons not yet understood. This echoes the pattern seen in rotator cuff injuries, where fatty infiltration, once established, resists reversal. The timing of intervention likely matters: preventing fat from accumulating in the first place, through maintained physical activity, appears far more effective than trying to remove it once it has taken hold.

How Doctors Detect and Measure Muscle Fat

Fatty infiltration is often discovered incidentally on imaging done for other reasons, such as an MRI for back pain or a CT scan during cancer staging. Both MRI and CT can quantify the amount of fat in muscle, and measurements from the two modalities correlate closely with each other. MRI-based techniques like the Dixon method, which separates water and fat signals, are considered the reference standard for quantification. CT uses a simpler approach based on how dense the muscle tissue appears: fattier muscle looks darker on CT because fat absorbs fewer X-rays than lean tissue.

Ultrasound is also used, particularly in clinical settings where MRI or CT would be impractical or expensive. The echo intensity of muscle on ultrasound, meaning how bright it appears, increases as fat replaces lean tissue. This correlates moderately to strongly with the fat measured between muscle fibers, though it is less good at detecting fat stored inside the muscle cells themselves. For clinical decision-making around surgery, such as whether a rotator cuff tear is still repairable, MRI grading of fatty infiltration often determines the surgical plan.

Mortality and Long-Term Health Consequences

Muscle fat is more than a marker of poor muscle quality; it predicts how long you live. The AGES-Reykjavik Study, a large population-based study of older adults, found that each standard-deviation increase in intramuscular fat was associated with a 23% higher risk of death in men and an 8% higher risk in women. Greater intermuscular fat carried a 13% increase in mortality risk for men. Meanwhile, greater muscle area, muscle quality, and strength were all associated with lower mortality risk. These associations held after accounting for overall body size and other health factors, pointing to myosteatosis as an independent threat rather than just a side effect of being overweight or frail.

In clinical medicine, the importance of myosteatosis is increasingly recognized in surgical and cancer settings. Patients with greater muscle fat infiltration before surgery tend to have more complications and slower recoveries. In oncology, myosteatosis at the time of cancer diagnosis has been linked to worse treatment tolerance and shorter survival across several cancer types. The field is moving toward routine assessment of muscle composition on scans patients are already getting, which would flag high-risk individuals before problems develop rather than after.